Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Acting Cabotegravir And Rilipivirine In People Living With HIV-1 Subtype A6. A Multicentre Real-world, Retrospective Matched Case Study

NCT07370649 is registered in ClinicalTrials.gov with Pomeranian Medical University Szczecin as lead sponsor.

NCT NCT07370649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07370649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Acting Cabotegravir And Rilipivirine In People Living With HIV-1 Subtype A6. A Multicentre Real-world, Retrospective Matched Case Study
Lead sponsor
Pomeranian Medical University Szczecin
Phase
Observational
Overall status
Recruiting
Start date
May 12, 2026
Completion date
March 31, 2027
Enrollment
250 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 subtype a6 infection, hiv-1 subtype b infection, human immunodeficiency virus (hiv)-1 infection, virologically suppressed hiv-1 infection receiving long-acting antiretroviral therapy